A Special Strategy for This Biotech Winner
This biotech company was my first pick for this newsletter a year and a half ago, in October 2013. As of Friday, it is up more than 330%. We bought it at $10.40 a share, and it has been bouncing around $45 a share.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.